What factors should be considered when deciding whether to screen for osteoporosis?

Factors to Consider When Deciding on Osteoporosis Screening

When deciding whether to screen for osteoporosis, prioritize age and sex first, then assess specific clinical risk factors using a structured two-step approach for younger postmenopausal women. 1

Primary Decision Framework

Age and Sex Thresholds

• Women ≥65 years: Screen universally—no additional risk stratification needed 1
• Postmenopausal women <65 years: Screen only if increased risk is present (see below) 1
• Men ≥70 years: Consider screening, though evidence is insufficient for firm recommendations 1
• Men 50-69 years: Screen if at least one major or two minor risk factors present 2

Two-Step Approach for Postmenopausal Women <65 Years

The 2025 USPSTF guideline recommends a structured approach 1:

Step 1: Identify Clinical Risk Factors

Major risk factors include:

• Low body weight (weight <57.4 kg has highest diagnostic accuracy) 3
• Parental history of hip fracture
• Current cigarette smoking
• Excess alcohol consumption
• Menopausal status 1

Step 2: Use Clinical Risk Assessment Tool

For women with ≥1 risk factor (beyond menopausal status), apply a fracture risk calculator:

• FRAX (most extensively studied, can be used with or without BMD) 1
• Fracture Risk Calculator (FRC) 1
• Garvan Fracture Risk Calculator 1

Screen if 10-year fracture risk shows:

• Major osteoporotic fracture risk ≥20%, OR
• Hip fracture risk ≥3% 4

Additional Clinical Factors

Medical Conditions and Medications

Consider screening regardless of age if:

• Chronic corticosteroid use (>1 month) 1, 5
• Diabetes treated with insulin 1
• History of fragility fracture (fall from standing height or lower) 1
• Height loss >2.54 cm 5

Critical pitfall: Patients with these risk factors are frequently under-screened despite clear indications 5

Race and Ethnicity Considerations

While fracture incidence varies by race/ethnicity, use the same screening thresholds for all groups 1. Key nuances:

• Asian, Black, and Hispanic populations have lower fracture incidence than White populations 1
• Asian women may have lower BMD but paradoxically lower fracture risk 1
• Differences likely reflect social, environmental, and clinical factors beyond BMD alone 1

Exclusions

Do not apply these screening recommendations to:

• Persons with known osteoporosis or prior fragility fractures
• Secondary osteoporosis from underlying conditions (cancer, metabolic bone disease, hyperthyroidism)
• Chronic medication-associated bone loss (already on glucocorticoids) 1

Key Clinical Pitfalls

1. Age is a stronger fracture predictor than BMD alone 1—older adults fracture more at the same BMD due to declining bone quality and fall risk
2. BMD alone insufficient for younger populations 1—always incorporate clinical risk factors
3. Weight is the single most effective simple predictor (AUC 0.664) compared to BMI (0.633) or age (0.558) 3
4. Physicians frequently miss screening opportunities in patients with oral steroid use, height loss, or prior low-trauma fractures 5

Practical Algorithm

Age ≥65 (women) or ≥70 (men) → Screen
    ↓ No
Postmenopausal woman <65 → Check risk factors
    ↓ Yes (≥1 risk factor)
Calculate FRAX score
    ↓
10-year MOF ≥20% OR hip fracture ≥3% → Screen

The evidence strongly supports that advancing age remains the most critical determinant of fracture risk, even more than bone density measurements alone 1, making age-based thresholds the cornerstone of screening decisions.